Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 3,722,800 | 3,435,300 | 2,963,700 | 2,493,700 | 2,322,900 |
| Cost of Goods | 939,400 | 875,300 | 797,400 | 617,200 | 625,600 |
| Gross Profit | 2,783,400 | 2,560,000 | 2,166,300 | 1,876,500 | 1,697,300 |
| Operating Expenses | 2,035,600 | 1,470,900 | 1,382,900 | 1,234,000 | 1,205,100 |
| Operating Income | 748,200 | 1,089,400 | 783,800 | 642,700 | 492,800 |
| Interest Expense | 29,900 | 23,200 | 19,200 | 17,200 | 17,200 |
| Other Income | 43,100 | -31,300 | -26,700 | -3,100 | 668,400 |
| Pre-tax Income | 761,400 | 1,034,900 | 737,900 | 622,400 | 1,144,000 |
| Income Tax | 39,200 | 451,300 | 168,400 | 127,500 | 332,900 |
| Net Income Continuous | 722,200 | 583,600 | 569,500 | 494,900 | 811,100 |
| Net Income | $722,200 | $583,600 | $569,500 | $494,900 | $811,100 |
| EPS Basic Total Ops | 1.15 | 0.92 | 0.89 | 0.77 | 1.27 |
| EPS Basic Continuous Ops | 1.15 | 0.92 | 0.89 | 0.77 | 1.27 |
| EPS Diluted Total Ops | 1.13 | 0.90 | 0.87 | 0.75 | 1.25 |
| EPS Diluted Continuous Ops | 1.13 | 0.90 | 0.87 | 0.75 | 1.25 |
| EPS Diluted Before Non-Recurring Items | 1.57 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $825,600 | $1,171,300 | $855,000 | $708,500 | $561,400 |